The U.S. Department of Justice (DOJ) filed a complaint against a pharmaceutical company, claiming it had manipulated reimbursements for its eye care drug, thereby defrauding the country’s federal health insurance program and taxpayers of hundreds of millions of dollars.
Related Posts
US and UK Sanction Georgian Officials Over Crackdown on Protesters
The U.S. and U.K. have imposed more sanctions on Georgian officials for violently suppressing protests in Tbilisi and… Read More
Singapore Money Laundering Suspects Spent Lavishly on Dubai Real Estate
Suspected members of a massive Singapore money laundering syndicate snapped up almost $30 million in Dubai properties,… Read More
EU to Investigate TikTok Over Romania’s Cancelled Presidential Elections
The European Commission has opened an investigation against TikTok for facilitating interference in Romania’s 2024… Read More